Policy options for state-based PCV rollout in India: The evidence base  by Sauer, M. et al.
162 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
Type: Poster Presentation
Final Abstract Number: 41.197
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Improving HIV service delivery in detention
centers and ART facility in Odessa, Ukraine
N.A. Rakhmanova1,∗, U. Snidevich2, I.
Semenenko2
1 FHI 360 and PromedMail, Silver Spring, Maryland,
USA
2 FHI360, Kiev, Ukraine
Background: Under USAID funded RESPOND project, a collab-
orative Quality Improvement (QI) effort was initiated in March
2013 with two detention centers and an Anti-retroviral treatment
(ART) site in Odessa; their respective aims were to improve the
HIV continuum of care among the rural population and to increase
the coverage of detainees with HIV Testing and Counseling (HTC)
services and enrolment in care. Before the improvement effort, in
2012, only 3.0% of detainees received HIV counseling, of which
19.2% were tested for HIV. Furthermore, there was no reliable
mechanism to link released HIV-positive detainees with ART ser-
vices.
Methods & Materials: The three sites applied a Plan-Do-Study-
Act QI Model to test changes; this model included teamwork
and coordination with the Odessa AIDS Center; monthly self-
monitoring against improvement indicators, QI coaching visits, and
sharing results during quarterly learning sessions. After 12 months
of implementation, a data review and qualitative assessment sur-
vey were conducted.
Results: Over one year, the two detention centers increased
the coverage of HIV counseling services for detainees from 44% to
nearly 70% . The coverage of HIV testing increased on average from
32% to 70%. The percentage of detainees that tested positive who
were enrolled in care with the AIDS Center increased from 0% to
40% after introduction of health system changes.
The ART Center increased the proportion of HIV patients
enrolled into care within 30 days after the conﬁrmatory HIV test
from55% to70% . Thepercentageofpatients thatunderwent regular
checkups increased from 42% (June 2013-October 2013) to 80%
Conclusion: The key results of the project were the following:
for the Odessa ART Center - 1) increased timely enrolment of HIV
positive individuals in care, and2) improved attendanceofHIVpos-
itive patients at regular check-ups; and 3) increased coverage with
HTC services. These results indicated that more people were diag-
nosed with HIV at an earlier stage and more of them were enrolled
in care in a timely manner and beneﬁtted from the known efﬁcacy
of ART.
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Background: One in ﬁve child deaths occur in India; pneumonia
and meningitis are major causes. Among Indian children aged 1-59
months, more than 160,000 deaths were attributed to pneumonia
or meningitis in 2015. Pneumococcus is the most common cause
of bacterial pneumonia, responsible for one-third of child pneumo-
nia deaths. It is vaccine-preventable and more than 130 countries
have introducedPCV into their national immunizationprograms. In
these countries, routine PCV use has virtually eliminated vaccine-
serotype pneumococcal pneumonia and invasive pneumococcal
disease, and reduced severe pneumonia and all-cause mortality.
However, PCV is not currently part of India’s Universal Immu-
nisation Programme (UIP). The relative health need and rollout
feasibility in each of Indian state was analyzed to develop policy
options for rollout.
Methods & Materials: This analysis considered indicators of
disease burden and mortality, access to and equity of care, gover-
nance, vaccine coverage, rollout capacity, and surveillance capacity.
Using available data, these indicators may be assessed and ranked
in identifying which states to include in the initial cohort.
Results: Policy options were identiﬁed based on the relative
ranking of each state on need and immediate feasibility. Under
eachselectionstrategy—needonly, immediate feasibilityonly,need
and feasibility, and surveillance capacity—we assumed an initial
rollout of 20% of the birth cohort. We applied DTP3 coverage to
state birth cohorts for an estimate on coverage under rollout sce-
narios. Under a need-based selection process, fewer states would
be able to introduce because of large size of the high need state
populations. Conversely, under a feasibility-based process the roll-
out cohort could include 15-20 states; states with high immediate
feasibility are signiﬁcantly smaller.
Conclusion: Introducing PCV into India’s UIP has the potential
to dramatically impact child morbidity and mortality. Decisions
around resource allocation depend on India’s priorities and needs;
analyzing state-level need and feasibility can inform state selection
through a structured data approach. Using available data to rank
states on key indicators allows for evidence-based policy options
to identify states for the initial rollout cohort. In selecting states for
initial phases of a potential PCV introduction, the Government of
India may use all or part of these options.
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